Pharmaceutical Technology· GlobalData Healthcare·· 14 小时前AI 评分12
ESMO26：Intismeran 在辅助治疗黑色素瘤中树立新标杆
ESMO26: Intismeran sets new benchmark in adjuvant melanoma
AI 导读
ESMO26 会议上，Intismeran 在辅助治疗黑色素瘤中树立新标杆。原文未披露具体临床数据、样本量及终点数值。
正文 · 原文
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends.
With a free Pharmaceutical Technology profile, you can:
- Access exclusive analyst commentary and expert insights
- View premium forecasts and data-driven pharmaceutical industry insights
- Stay up to date with pharma news, manufacturing innovation, and regulatory developments
- Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here
Powered by
来源：Pharmaceutical Technology · pharmaceutical-technology.com